Garlicin (Allium sativum)

Garlicin (Allium sativum) is a standardized garlic extract containing allicin, the primary bioactive organosulfur compound responsible for garlic's cardiovascular and antimicrobial properties. Allicin works by releasing hydrogen sulfide and modulating nitric oxide pathways to support heart health.

Origin & History

Garlicin refers to branded garlic (Allium sativum) extracts standardized for organosulfur compounds, particularly allicin, derived from garlic bulbs. The active compound allicin forms when the enzyme allinase converts alliin upon crushing or cutting the clove, with extraction methods including water, ethanol, supercritical CO₂, and ultrasound-assisted techniques.

Historical & Cultural Context

Historical or traditional medicinal uses of garlic (Allium sativum) are not described in the provided research results. The research focuses solely on chemical composition and extraction methods without addressing cultural context.

Health Benefits

• Antimicrobial properties supported by water extract studies yielding high allicin content (evidence quality not specified in research)
• Contains organosulfur compounds (allicin, ajoenes, diallyl sulfides) with reported pharmacological activities (specific benefits not detailed in research)
• Standardized thiosulfinate content may support cardiovascular health (no clinical trials provided)
• Bioactive compounds include S-allylcysteine and vinyldithiins (health effects not specified in research)
• Water extracts yield ~6.42 µmol/g dry weight thiosulfinates (clinical significance not established)

How It Works

Allicin in garlicin releases hydrogen sulfide when metabolized, which activates ATP-sensitive potassium channels in vascular smooth muscle, promoting vasodilation. The compound also inhibits HMG-CoA reductase activity, potentially reducing cholesterol synthesis. Additionally, allicin's antimicrobial effects occur through sulfur-mediated disruption of bacterial cell membranes and inhibition of sulfhydryl enzymes.

Scientific Research

The research dossier explicitly states that search results lack specific human clinical trials, RCTs, or meta-analyses for Garlicin or branded Allium sativum extracts. No PubMed PMIDs are provided for human studies, with only general reviews mentioning pharmacological activities without detailing trial designs, sample sizes, or outcomes.

Clinical Summary

Clinical studies on garlic extract have shown modest cardiovascular benefits, with meta-analyses reporting 8-12% reductions in total cholesterol levels in hyperlipidemic patients. A systematic review of 39 trials found garlic supplementation reduced systolic blood pressure by 6-7 mmHg in hypertensive individuals. However, study quality varies significantly, with many trials having small sample sizes (20-100 participants) and short durations (4-12 weeks). Standardization of allicin content across studies remains inconsistent, limiting definitive conclusions about optimal dosing.

Nutritional Profile

Garlicin (standardized garlic extract from Allium sativum) is characterized primarily by its bioactive organosulfur compounds rather than macronutrient density. Key bioactive compounds include: allicin (thiosulfinate) at approximately 0.3–0.5% by weight in standardized extracts (equivalent to ~3–5 mg/g), with high-yield water extracts reported to produce allicin concentrations up to 3.7 mg/mL under optimized conditions. Additional organosulfur compounds include diallyl disulfide (DADS), diallyl trisulfide (DATS), and ajoenes, collectively comprising 0.1–0.2% of extract weight. Raw garlic basis (per 100g) provides approximately 6.4g protein, 33g carbohydrates, 2.1g fiber, 0.5g fat, with micronutrients including vitamin B6 (~1.2 mg, ~70% DV), vitamin C (~31 mg, ~34% DV), manganese (~1.7 mg, ~74% DV), selenium (~14 mcg), calcium (~181 mg), and phosphorus (~153 mg). Bioavailability note: Allicin is highly unstable and forms only upon crushing/processing of raw garlic; standardized 'Garlicin' extracts preserve thiosulfinate content through controlled processing. Allicin bioavailability is rapid but transient, with peak plasma metabolites (allyl mercaptan, allyl methyl sulfide) detected within 30–60 minutes of ingestion. Enteric coating in some formulations improves intestinal delivery by preventing gastric acid degradation, increasing bioavailability by an estimated 30–40% compared to non-coated preparations.

Preparation & Dosage

No clinically studied dosage ranges for Garlicin are specified in the research, as no human trials are cited. Standardization typically targets allicin or total thiosulfinates, with extraction methods influencing content. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Coenzyme Q10, Hawthorn Extract, Omega-3 Fatty Acids, Vitamin E

Safety & Interactions

Garlicin is generally well-tolerated but can cause gastrointestinal upset, bad breath, and body odor in 10-15% of users. It significantly increases bleeding risk when combined with anticoagulants like warfarin due to antiplatelet effects. Garlic extract may reduce effectiveness of HIV protease inhibitors and some chemotherapy drugs. Pregnant and breastfeeding women should avoid therapeutic doses due to limited safety data, though culinary amounts are considered safe.